Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Klingauf J, Kavalali ET, Tsien RW
Transitional changes in medication-initiator cohort profiles in persons with chronic kidney disease and type 2 diabetesa hospital-based cohort study in Japan
The investigators pre-select what is referred to as a primary outcome
The complete list of metabolites reported in urine and bloodtogether with their identifiers from the Human Metabolome Database (HMDB) (Wishart et al., 2022), PubChem, KEGG and SMILES annotation
Populations at elevated risk are people on blood thinners, immune suppression, and those with severe kidney or liver disease
US$ 20.42
US$ 23.09
US$ 21.68
US$ 22.89
